Correlation Between Indaptus Therapeutics and Genelux Common

Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Genelux Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Genelux Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Indaptus Therapeutics and Genelux Common, you can compare the effects of market volatilities on Indaptus Therapeutics and Genelux Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Genelux Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Genelux Common.

Diversification Opportunities for Indaptus Therapeutics and Genelux Common

-0.1

Correlation Coefficient

Indaptus Therapeutics  Genelux Common

Good diversification

The 3 months correlation between Indaptus and Genelux is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Genelux Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genelux Common and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Genelux Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genelux Common has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Genelux Common go up and down completely randomly.

Pair Corralation between Indaptus Therapeutics and Genelux Common

Given the investment horizon of 90 days Indaptus Therapeutics is expected to under-perform the Genelux Common. In addition to that, Indaptus Therapeutics is 1.27 times more volatile than Genelux Common. It trades about -0.06 of its total potential returns per unit of risk. Genelux Common is currently generating about 0.03 per unit of volatility. If you would invest  254.00  in Genelux Common on September 14, 2024 and sell it today you would lose (2.00) from holding Genelux Common or give up 0.79% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Indaptus Therapeutics  vs.  Genelux Common

Indaptus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Indaptus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Genelux Common

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Genelux Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Genelux Common may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Indaptus Therapeutics and Genelux Common

The main advantage of trading using opposite Indaptus Therapeutics and Genelux Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Genelux Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genelux Common will offset losses from the drop in Genelux Common's long position.

The idea behind Indaptus Therapeutics and Genelux Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.